Petpharm
PrivateLast Round
Series B
May 8, 2025
Est. Valuation
$3.04M
Total Funding Raised
$7.77M
Company Overview
Petpharm is a veterinary pharmaceutical company that operates a B2B platform for veterinary pharmacies and manufactures animal healthcare products.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, E-commerce, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Marketplace Commission
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Petpharm Comparables
Compare Petpharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vet-Nine | 77% | |
| VetTec Korea | 71% | |
| KOREA THUMB VET Co., Ltd. | 63% |
Petpharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 8, 2025 | ||||
| Series A | Aug 8, 2023 | ||||
| Pre Seed | Dec 2, 2021 | ||||
| Crowdfunding | Oct 21, 2021 |
Petpharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eugene Asset Management | Series B, Series A |
| Banks Foundation for Young Entrepreneurs | Series B |
| CRIT Ventures | Series B |
| STIC Ventures | Series B |
| Korea Investment Partners | Series A |
| Korea Credit Guarantee Fund | Series A |
| New Paradigm Investment | Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2025
$4.55M round led by CRIT Ventures and STIC Ventures.
- Aug 8, 2023
$2.56M round led by Korea Investment Partners.
Petpharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Petpharm's valuation, stock price, and market status.
Is Petpharm a public or private company?
Petpharm is a private company.
What is the current stock price of Petpharm?
Petpharm is a private company with no public stock price. Caplight tracks Petpharm's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Petpharm worth (valuation)?
Petpharm's valuation is estimated at $3.0M based on funding round data.
Can I buy Petpharm stock?
Petpharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Petpharm's last funding round?
Petpharm's most recent funding round was Series B on October 21, 2021.
Who are the main investors in Petpharm?
Key investors in Petpharm include Korea Investment Partners.
Will Petpharm IPO soon?
No public IPO plans have been announced for Petpharm.
How can I track Petpharm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Petpharm's secondary market activity and sign up for updates.